Publication | Open Access
Predicting the Risk for Dialysis or Death in IgA Nephropathy
360
Citations
33
References
2011
Year
Glomerular DiseaseHypertensionRenal PathologyRenal InflammationDialysis TherapyGlomerulonephritisRenal FunctionIga GlomerulonephritisAbsolute Renal RiskBiopsy-proven Igan PatientsIga NephropathyPublic HealthAcute Kidney InjuryChronic Kidney DiseaseRenal PharmacologyHemodialysisRenal CareKidney FailureRenal PathophysiologyRisk FactorsEnd-stage Renal DiseaseEpidemiologyUrologyRenal DiseaseCardiovascular DiseaseDiabetesMedicineNephrology
For the individual patient with primary IgA nephropathy (IgAN), it remains a challenge to predict long-term outcomes for patients receiving standard treatment. We studied a prospective cohort of 332 patients with biopsy-proven IgAN patients followed over an average of 13 years. We calculated an absolute renal risk (ARR) of dialysis or death by counting the number of risk factors present at diagnosis: hypertension, proteinuria ≥1 g/d, and severe pathologic lesions (global optical score, ≥8). Overall, the ARR score allowed significant risk stratification (P < 0.0001). The cumulative incidence of death or dialysis at 10 and 20 years was 2 and 4%, respectively, for ARR=0; 2 and 9% for ARR=1; 7 and 18% for ARR=2; and 29 and 64% for ARR=3, in adequately treated patients. When achieved, control of hypertension and reduction of proteinuria reduced the risk for death or dialysis. In conclusion, the absolute renal risk score, determined at diagnosis, associates with risk for dialysis or death.
| Year | Citations | |
|---|---|---|
Page 1
Page 1